MMSI - Merit Medical Systems Inc Stock Price, Fair Value and News

80.54USD+1.03 (+1.30%)Delayed as of 07 May 2024, 10:53 am ET

Market Summary

USD80.54+1.03

Delayedas of 07 May 2024, 10:53 am

1.30%

MMSI Alerts

Big jump in Earnings (Y/Y)

MMSI Stock Price

View Fullscreen

MMSI RSI Chart

MMSI Valuation

Market Cap

4.6B

Price/Earnings (Trailing)

45.32

Price/Sales (Trailing)

3.6

EV/EBITDA

20.54

Price/Free Cashflow

34.57

MMSI Price/Sales (Trailing)

MMSI Profitability

EBT Margin

9.42%

Return on Equity

8.22%

Return on Assets

4.38%

Free Cashflow Yield

2.89%

MMSI Fundamentals

MMSI Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

8.72%

Rev. Growth (Qtr)

-0.31%

MMSI Earnings

Earnings (TTM)

101.9M

Earnings Growth (Yr)

36.41%

Earnings Growth (Qtr)

2.21%

Breaking Down MMSI Revenue

52 Week Range

62.6785.62

(Low)(High)

Last 7 days

5.9%

Last 30 days

9.9%

Last 90 days

1.1%

Trailing 12 Months

-6.3%

How does MMSI drawdown profile look like?

MMSI Financial Health

Current Ratio

6.03

Debt/Equity

0.65

Debt/Cashflow

0.21

MMSI Investor Care

Shares Dilution (1Y)

1.06%

Diluted EPS (TTM)

1.75

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.3B	0	0	0
2023	1.2B	1.2B	1.2B	1.3B
2022	1.1B	1.1B	1.1B	1.2B
2021	969.3M	1.0B	1.1B	1.1B
2020	1.0B	962.9M	963.8M	963.9M
2019	918.1M	948.8M	970.2M	994.9M
2018	759.8M	798.1M	840.4M	882.8M
2017	636.8M	672.3M	694.7M	727.9M
2016	550.6M	563.6M	584.5M	603.8M
2015	520.0M	529.2M	536.5M	542.1M
2014	464.3M	483.3M	496.9M	509.7M
2013	402.6M	412.0M	431.3M	449.0M
2012	368.4M	377.7M	383.1M	394.3M
2011	316.0M	332.3M	349.6M	359.4M
2010	0	270.6M	283.7M	296.8M
2009	0	0	0	257.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Merit Medical Systems Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 14, 2024	lloyd brian g.	gifted	-	-	-1,180	chief legal officer, secretary
Mar 12, 2024	parra raul jr.	sold	-479,182	73.9479	-6,480	cfo and treasurer
Mar 07, 2024	wright joseph	acquired	705,000	28.2	25,000	chief commercial officer
Mar 07, 2024	wright joseph	sold	-1,891,920	75.677	-25,000	chief commercial officer
Mar 06, 2024	peterson neil	acquired	336,000	44.8	7,500	chief operating officer
Mar 06, 2024	voigt michel james	gifted	-	-	-315	chief human resources officer
Mar 04, 2024	voigt michel james	sold (taxes)	-201,221	76.51	-2,630	chief human resources officer
Mar 04, 2024	wright joseph	sold (taxes)	-201,221	76.51	-2,630	chief commercial officer
Mar 04, 2024	wright joseph	acquired	-	-	14,429	chief commercial officer
Mar 04, 2024	gunderson thomas james	sold	-1,380,510	76.032	-18,157	-

Which funds bought or sold MMSI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 03, 2024	Smartleaf Asset Management LLC	new	-	382	382	-%
May 03, 2024	OREGON PUBLIC EMPLOYEES RETIREMENT FUND	reduced	-8.28	-109,601	1,174,810	0.02%
May 03, 2024	VICTORY CAPITAL MANAGEMENT INC	reduced	-14.03	-763,193	4,584,090	-%
May 03, 2024	HUNTINGTON NATIONAL BANK	added	16.6	14,599	104,308	-%
May 03, 2024	SIGNATUREFD, LLC	reduced	-4.29	-564	11,817	-%
May 02, 2024	LGT Financial Advisors LLC	unchanged	-	-13.00	5,000	0.01%
May 02, 2024	JENNISON ASSOCIATES LLC	reduced	-37.12	-389,972	655,693	-%
May 02, 2024	Fidelis Capital Partners, LLC	new	-	427,977	427,977	0.06%
May 02, 2024	FORA Capital, LLC	new	-	577,064	577,064	0.05%
May 02, 2024	South Dakota Investment Council	reduced	-5.59	-56,000	895,000	0.02%

Are Funds Buying or Selling MMSI?

Are funds buying MMSI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MMSI

No. of Funds

MMSI Alerts

Big jump in Earnings (Y/Y)

Unveiling Merit Medical Systems Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.92%	6,884,723	SC 13G/A
Feb 12, 2024	william blair investment management, llc	6.6%	3,791,089	SC 13G/A
Jan 22, 2024	blackrock inc.	17.4%	10,067,008	SC 13G/A
Feb 15, 2023	arrowmark colorado holdings llc	4.42%	2,517,226	SC 13G/A
Feb 09, 2023	william blair investment management, llc	6.6%	3,729,980	SC 13G/A
Feb 09, 2023	vanguard group inc	11.99%	6,824,344	SC 13G/A
Jan 26, 2023	blackrock inc.	17.0%	9,670,688	SC 13G/A
Jan 20, 2023	blackrock inc.	17.0%	9,670,688	SC 13G/A
Feb 14, 2022	arrowmark colorado holdings llc	5.51%	3,111,000	SC 13G/A
Feb 10, 2022	william blair investment management, llc	5.9%	3,357,638	SC 13G/A

Recent SEC filings of Merit Medical Systems Inc

View All Filings

Date Filed	Form Type	Document
Apr 30, 2024	10-Q	Quarterly Report
Apr 30, 2024	8-K	Current Report
Apr 02, 2024	ARS	ARS
Apr 02, 2024	ARS/A	ARS/A
Apr 02, 2024	DEF 14A	DEF 14A
Apr 02, 2024	DEFA14A	DEFA14A
Mar 15, 2024	4	Insider Trading
Mar 13, 2024	4	Insider Trading
Mar 12, 2024	144	Notice of Insider Sale Intent
Mar 08, 2024	4	Insider Trading

Peers (Alternatives to Merit Medical Systems Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	183.8B	40.3B	-5.00%	-5.05%	32.67	4.56	-2.84%	-3.08%
BDX	68.4B	19.7B	-3.90%	-6.73%	51.29	3.47	4.82%	-17.56%
ALGN	21.6B	3.9B	-9.51%	-8.38%	46.8	5.52	5.72%	46.72%
BAX	18.6B	14.9B	-14.34%	-20.72%	7.02	1.25	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	5.17%	22.48%	31.57	2.79	6.16%	35.06%
HSIC	8.8B	12.3B	-5.50%	-14.07%	21.17	0.71	-2.44%	-22.68%
BIO	8.2B	2.7B	-13.13%	-26.81%	-12.92	3.08	-4.68%	82.43%
XRAY	5.9B	3.9B	-12.57%	-31.60%	-62.73	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.38%	28.89%	-216.43	8.91	30.82%	65.57%
PDCO	2.3B	6.6B	-1.94%	-3.23%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.4B	3.2B	1.24%	-9.09%	-2.08	0.44	7.73%	-1066.14%
ANIK	413.1M	166.7M	8.74%	7.69%	-5	2.48	6.67%	-456.34%
ANGO	248.3M	324.0M	-11.81%	-28.90%	-1.29	0.77	-3.19%	-337.41%
APYX	48.5M	52.3M	-5.33%	-58.72%	-2.59	0.93	17.61%	19.28%
AEMD	3.4M	3.7M	-24.57%	300.00%	-0.28	0.92	5.77%	8.23%

Merit Medical Systems Inc News

Latest updates

Merit Medical Systems Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-0.3%	324	325	315	320	298	293	287	295	275	278	267	280	249	258	244	218	244	258	243	256	238
Gross Profit	0.8%	152	151	142	153	138	135	129	135	121	129	120	124	112	111	102	84.00	104	112	104	112	105
Operating Expenses	-1.0%	116	117	107	124	112	104	110	112	106	107	105	115	98.00	95.00	102	103	102	115	107	100	95.00
S&GA Expenses	-1.4%	94.00	96.00	87.00	101	90.00	83.00	90.00	85.00	84.00	77.00	86.00	92.00	81.00	80.00	72.00	67.00	79.00	82.00	87.00	80.00	78.00
R&D Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.00	16.00
EBITDA Margin	6.1%	0.18*	0.17*	0.17*	0.16*	0.16*	0.15*	0.14*	0.14*	0.13*	0.13*	0.13*	0.12*	-	-	-	-	-	-	-	-	-
Interest Expenses	61.7%	8.00	5.00	5.00	4.00	2.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	2.00	2.00	2.00	3.00	3.00	3.00	3.00	3.00	3.00
Income Taxes	59.1%	6.00	4.00	4.00	5.00	5.00	-3.25	2.00	5.00	4.00	-0.43	2.00	2.00	2.00	-2.13	1.00	-3.24	1.00	-3.76	-2.29	2.00	1.00
Earnings Before Taxes	9.2%	34.00	31.00	30.00	25.00	26.00	30.00	18.00	21.00	14.00	20.00	14.00	7.00	13.00	13.00	-2.18	-22.30	-1.99	-7.96	-5.69	9.00	7.00
EBT Margin	5.7%	0.09*	0.09*	0.09*	0.08*	0.08*	0.07*	0.06*	0.06*	0.05*	0.05*	0.04*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	2.2%	28.00	28.00	26.00	20.00	21.00	33.00	15.00	15.00	11.00	21.00	12.00	5.00	11.00	15.00	-3.01	-19.06	-3.15	-4.20	-3.40	7.00	6.00
Net Income Margin	5.8%	0.08*	0.08*	0.08*	0.07*	0.07*	0.06*	0.05*	0.05*	0.04*	0.05*	0.04*	0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	-55.5%	25.00	55.00	42.00	12.00	2.00	16.00	20.00	32.00	2.00	37.00	18.00	35.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.0%	2,326	2,325	1,809	1,838	1,684	1,664	1,633	1,632	1,630	1,648	1,643	1,642	1,652	1,664	1,671	1,716	1,749	1,757	1,762	1,736	1,690
Current Assets	-0.3%	1,105	1,108	585	595	557	529	500	493	478	482	463	450	438	430	435	446	463	455	441	427	422
Cash Equivalents	-0.9%	582	587	59.00	72.00	58.00	61.00	51.00	63.00	54.00	68.00	69.00	70.00	59.00	57.00	45.00	50.00	50.00	44.00	37.00	35.00	50.00
Inventory	-0.4%	303	304	304	306	290	266	247	233	231	222	208	195	200	198	209	221	228	226	217	203	199
Net PPE	0.0%	384	384	383	384	387	383	376	371	372	372	373	374	378	383	384	384	385	379	367	351	341
Goodwill	-0.2%	382	382	381	382	360	360	358	360	361	362	362	363	363	364	354	353	352	353	352	352	-
Liabilities	-3.3%	1,086	1,123	579	634	512	520	544	558	573	608	630	650	675	706	737	787	809	807	812	786	750
Current Liabilities	-9.9%	183	204	187	190	216	221	213	196	204	236	213	211	208	185	186	174	165	182	153	177	178
Long Term Debt	-2.8%	800	823	282	335	186	187	205	236	243	234	271	285	313	344	350	403	438	432	432	385	362
LT Debt, Current	-	-	-	4.00	4.00	11.00	11.00	11.00	10.00	9.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	15.00	22.00
LT Debt, Non Current	-2.8%	800	823	282	335	186	187	205	236	243	234	271	285	313	344	350	403	438	432	432	385	362
Shareholder's Equity	3.2%	1,240	1,202	1,230	1,204	1,172	1,144	1,089	1,073	1,057	1,040	1,013	992	977	959	934	929	940	950	949	951	940
Retained Earnings	4.9%	603	575	548	522	501	481	447	432	417	406	386	374	369	358	342	345	364	368	373	377	370
Accumulated Depreciation	2.4%	337	329	327	320	311	303	300	294	288	281	277	273	266	261	255	248	239	232	230	222	215
Shares Outstanding	0.4%	58.00	58.00	58.00	58.00	57.00	57.00	57.00	57.00	57.00	56.00	56.00	56.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	4,700	-	-	-	3,000	-	-	-	3,600	-	-	-	2,500	-	-	-	3,200	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-41.8%	36.00	62.00	51.00	17.00	15.00	28.00	35.00	39.00	12.00	46.00	25.00	41.00	35.00	37.00	55.00	44.00	29.00	27.00	15.00	22.00	14.00
Share Based Compensation	-12.6%	5.00	6.00	6.00	6.00	4.00	4.00	5.00	4.00	5.00	5.00	5.00	3.00	4.00	4.00	4.00	3.00	3.00	2.00	3.00	3.00	2.00
Cashflow From Investing	-164.3%	-22.05	-8.34	-9.25	-142	-14.86	-17.33	-16.77	-13.43	-9.87	-14.61	-7.29	-8.91	-6.35	-21.87	-9.36	-12.65	-14.76	-20.57	-39.11	-53.75	-21.05
Cashflow From Financing	-103.8%	-18.00	473	-54.55	142	-0.50	-5.75	-27.07	-13.20	-14.24	-32.47	-17.89	-21.83	-26.25	-4.55	-51.98	-32.95	-6.23	-0.17	26.00	18.00	-9.82

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

MMSI Income Statement

2024-03-31

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 323,508	$ 297,565
Cost of sales	171,793	159,203
Gross profit	151,715	138,362
Operating expenses:
Selling, general and administrative	94,428	90,144
Research and development	21,482	21,314
Contingent consideration (benefit) expense	(117)	521
Total operating expenses	115,793	111,979
Income from operations	35,922	26,383
Other income (expense):
Interest income	7,276	131
Interest expense	(8,046)	(2,011)
Other income (expense) - net	(804)	997
Total other expense - net	(1,574)	(883)
Income before income taxes	34,348	25,500
Income tax expense	6,108	4,797
Net income	$ 28,240	$ 20,703
Earnings per common share
Basic (in dollars per share)	$ 0.49	$ 0.36
Diluted (in dollars per share)	$ 0.48	$ 0.36
Weighted average shares outstanding
Basic (in shares)	57,958	57,352
Diluted (in shares)	58,567	58,183

MMSI Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 581,921	$ 587,036
Trade receivables - net of allowance for credit losses - 2024 - $9,327 and 2023 - $9,023	180,663	177,885
Other receivables	10,980	10,517
Inventories	302,733	303,871
Prepaid expenses and other current assets	24,437	24,286
Prepaid income taxes	4,088	4,016
Income tax refund receivables	453	859
Total current assets	1,105,275	1,108,470
Property and equipment:
Land and land improvements	25,982	26,017
Buildings	191,218	191,491
Manufacturing equipment	327,628	316,930
Furniture and fixtures	63,790	63,044
Leasehold improvements	53,772	53,638
Construction-in-progress	58,296	61,439
Total property and equipment	720,686	712,559
Less accumulated depreciation	(337,025)	(329,036)
Property and equipment - net	383,661	383,523
Other assets:
Goodwill	381,539	382,240
Deferred income tax assets	7,072	7,288
Right-of-use operating lease assets	72,639	63,047
Other assets	58,682	54,793
Total other assets	837,416	833,251
Total assets	2,326,352	2,325,244
Current liabilities:
Trade payables	48,377	65,944
Accrued expenses	113,220	120,447
Short-term operating lease liabilities	12,472	12,087
Income taxes payable	9,275	5,086
Total current liabilities	183,344	203,564
Long-term debt	800,136	823,013
Deferred income tax liabilities	5,519	5,547
Long-term income taxes payable	347	347
Liabilities related to unrecognized tax benefits	1,912	1,912
Deferred compensation payable	18,228	17,167
Deferred credits	1,579	1,605
Long-term operating lease liabilities	60,141	56,259
Other long-term obligations	14,956	13,830
Total liabilities	1,086,162	1,123,244
Commitments and contingencies
Stockholders' equity:
Preferred stock - 5,000 shares authorized; no shares issued as of March 31, 2024 and December 31, 2023
Common stock, no par value; 100,000 shares authorized; issued and outstanding as of March 31, 2024 - 58,102 and December 31, 2023 - 57,858	649,222	638,150
Retained earnings	603,424	575,184
Accumulated other comprehensive loss	(12,456)	(11,334)
Total stockholders' equity	1,240,190	1,202,000
Total liabilities and stockholders' equity	2,326,352	2,325,244
Developed technology
Other assets:
Intangible assets:	277,085	283,999
Other
Other assets:
Intangible assets:	$ 40,399	$ 41,884

About Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

CEO	Mr. Fred P. Lampropoulos
WEBSITE	merit.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	6846

Merit Medical Systems Inc Frequently Asked Questions

What is the ticker symbol for Merit Medical Systems Inc? What does MMSI stand for in stocks?

MMSI is the stock ticker symbol of Merit Medical Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Merit Medical Systems Inc (MMSI)?

As of Mon May 06 2024, market cap of Merit Medical Systems Inc is 4.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MMSI stock?

You can check MMSI's fair value in chart for subscribers.

What is the fair value of MMSI stock?

You can check MMSI's fair value in chart for subscribers. The fair value of Merit Medical Systems Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Merit Medical Systems Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MMSI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Merit Medical Systems Inc a good stock to buy?

The fair value guage provides a quick view whether MMSI is over valued or under valued. Whether Merit Medical Systems Inc is cheap or expensive depends on the assumptions which impact Merit Medical Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MMSI.

What is Merit Medical Systems Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon May 06 2024, MMSI's PE ratio (Price to Earnings) is 45.32 and Price to Sales (PS) ratio is 3.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MMSI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Merit Medical Systems Inc's stock?

In the past 10 years, Merit Medical Systems Inc has provided 0.198 (multiply by 100 for percentage) rate of return.